23 results on '"McKay O"'
Search Results
2. I am your fragment/you are my run-on.
- Author
-
McKay, O.
- Subjects
- I Am Your Fragment/You Are My Run-On (Poem), MCKAY, O.
- Abstract
The poem "I am your fragment/you are my run-on" by O. McKay is presented. First Line: i am your fragment; Last Line: to my miserable beginning.
- Published
- 2014
3. fame monster.
- Author
-
McKay, O.
- Subjects
- FAME Monster (Poem), MCKAY, O.
- Abstract
The poem "fame monster" by O. McKay is presented. First Line: fame devoured me whole; Last Line: while sampling someone else.
- Published
- 2014
4. expired tuna in a bloated can.
- Author
-
McKay, O.
- Subjects
- EXPIRED tuna in a bloated can (Poem), MCKAY, O.
- Abstract
The poem "expired tuna in a bloated can" by O. McKay is presented. First Line: i cough and gag; Last Line: in a bloated can.
- Published
- 2014
5. Midnight in Paris.
- Author
-
Mckay, O.
- Subjects
- MIDNIGHT in Paris (Film), ALLEN, Woody, 1935-
- Published
- 2014
6. Poem for the World.
- Author
-
McKay, O.
- Subjects
EARTH (Planet) in literature - Abstract
The poem "Poem for the World" by O. McKay from Dale City, Virginia is presented. First Line: The world holds us; Last Line: Crunch!
- Published
- 2013
7. To Kill a Mockingbird.
- Author
-
McKay, O.
- Subjects
CHILDREN in literature ,FICTION - Abstract
The article reviews the book "To Kill a Mockingbird," by Harper Lee.
- Published
- 2013
8. The Good Earth.
- Author
-
McKay, O.
- Subjects
FAIRY tales ,FICTION - Abstract
The article review the book "The Good Earth," by Pearl S. Buck.
- Published
- 2013
9. Safety and efficacy of physician-administered balanced-sedation for the endoscopic mucosal resection of large non-pedunculated colorectal polyps.
- Author
-
Gupta S, Kurup R, Shahidi N, Vosko S, McKay O, Zahid S, Whitfield A, Lee EY, Williams SJ, Burgess NG, and Bourke MJ
- Abstract
Background and study aims Because of concerns about peri-procedural adverse events (AEs), guidelines recommend anesthetist-managed sedation (AMS) for long and complex endoscopic procedures. The safety and efficacy of physician-administered balanced sedation (PA-BS) for endoscopic mucosal resection (EMR) of large non-pedunculated colorectal polyps (LNPCPs) ≥20 mm is unknown. Patients and methods We compared PA-BS with AMS in a retrospective study of prospectively collected data from consecutive patients referred for management of LNPCPs (NCT01368289; NCT02000141). A per-patient propensity analysis was performed following a 1:2 nearest-neighbor (Greedy-type) match, based on age, gender, Charlson comorbidity index, and lesion size. The primary outcome was any peri-procedural AE, which included hypotension, hypertension, tachycardia, bradycardia, hypoxia, and new arrhythmia. Secondary outcomes were unplanned admissions, 28-day re-presentation, technical success, and recurrence. Results Between January 2016 and June 2020, 700 patients underwent EMR for LNPCPs, of whom 638 received PA-BS. Among them, the median age was 70 years (interquartile range [IQR] 62-76 years), size 35 mm (IQR 25-45 mm), and duration 35 minutes (IQR 25-60 minutes). Peri-procedural AEs occurred in 149 (23.4%), most commonly bradycardia (116; 18.2%). Only five (0.8%) required an unplanned sedation-related admission due to AEs (2 hypotension, 1 arrhythmia, 1 bradycardia, 1 hypoxia), with a median inpatient stay of 1 day (IQR 1-3 days). After propensity-score matching, there were no differences between PA-BS and AMS in peri-procedural AEs, unplanned admissions, 28-day re-presentation rates, technical success or recurrence. Conclusions Physician-administered balanced sedation for the EMR of LNPCPs is safe. Peri-procedural AEs are infrequent, transient, rarely require admission (<1%), and are experienced in similar frequencies to those receiving anesthetist-managed sedation., Competing Interests: Conflict of Interest Michael J. Bourke: research support from Olympus Medical, Cook Medical and Boston Scientific. The remaining authors have no conflicts of interest to disclose., (The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).)
- Published
- 2024
- Full Text
- View/download PDF
10. Endoscopic ultrasonography-guided gastroenterostomy to relieve biliary obstruction due to afferent limb syndrome in complex postsurgical anatomy.
- Author
-
Reynauld B, Ratinam R, McKay O, and Croagh D
- Subjects
- Humans, Endosonography, Gastroenterostomy, Ultrasonography, Interventional, Stents, Cholestasis diagnostic imaging, Cholestasis etiology, Cholestasis surgery, Gastric Outlet Obstruction surgery
- Published
- 2023
- Full Text
- View/download PDF
11. Effect of Adding a Wheelchair Immersion Program to a Physical Medicine and Rehabilitation Clerkship on Emotions, Behavior, and Attitude: A Prospective Pilot Study.
- Author
-
Hsieh S, Donovan J, Fyffe D, McKay O, and Kirshblum S
- Subjects
- Activities of Daily Living, Attitude, Curriculum, Emotions, Humans, Pilot Projects, Prospective Studies, Clinical Clerkship, Physical and Rehabilitation Medicine, Wheelchairs
- Abstract
Abstract: People with disabilities encounter significant barriers in health care and report that healthcare providers often lack an understanding in caring for them. Currently, there is limited disability awareness training in medical school curricula. This mixed-methods pilot study examined the effects of integrating a short wheelchair immersion program in a physical medicine and rehabilitation clerkship, versus the clerkship alone, on attitudes toward people with disabilities, comfort in treating people with disabilities, knowledge of wheelchair etiquette, and understanding of wheelchair-associated challenges. The standard training group underwent the physical medicine and rehabilitation clerkship, consisting of a 2-wk clinical rotation and didactic program. The intervention group additionally underwent a newly developed 1-hr wheelchair program where they simulated mobility and some activities of daily living as a "wheelchair user" and "caregiver." Quantitative analysis demonstrated that all students who completed the clerkship had significantly improved attitudes toward and comfort in treating people with disabilities, knowledge of wheelchair etiquette, and understanding of wheelchair-associated challenges, whereas students in the wheelchair immersion program had a greater change in understanding wheelchair-associated challenges. Qualitative analysis revealed that the intervention resulted in positive attitudinal changes. These findings suggest that integrating a brief wheelchair immersion program with a physical medicine and rehabilitation clerkship may enhance disability awareness training in medical school curricula., Competing Interests: Financial disclosure statements have been obtained, and no conflicts of interest have been reported by the authors or by any individuals in control of the content of this article., (Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
12. Painless idiopathic neuralgic amyotrophy after COVID-19 vaccination: A case report.
- Author
-
Diaz-Segarra N, Edmond A, Gilbert C, Mckay O, Kloepping C, and Yonclas P
- Subjects
- Humans, Vaccination adverse effects, Brachial Plexus Neuritis diagnosis, Brachial Plexus Neuritis etiology, COVID-19, COVID-19 Vaccines adverse effects
- Published
- 2022
- Full Text
- View/download PDF
13. Spasticity management and resolution of paroxysmal sympathetic hyperactivity in the acute care setting: a case series.
- Author
-
Edmond A, McKay O, Mehta N, Dabaghian L, and Yonclas P
- Subjects
- Humans, Muscle Spasticity drug therapy, Muscle Spasticity etiology, Psychomotor Agitation, Autonomic Nervous System Diseases etiology, Brain Injuries, Traumatic complications, Brain Injuries, Traumatic therapy, Dystonia drug therapy, Dystonia etiology, Dystonic Disorders etiology, Dystonic Disorders therapy
- Abstract
Objective: The aim is to highlight three cases of focal spasticity and/or dystonia as potential noxious triggers and treatment targets of Paroxysmal Sympathetic Hyperactivity (PSH)., Methods: We review the literature, explore pathophysiology, and review treatment options. We discuss the clinical course and management of three unique patients who presented to a teaching hospital with severe traumatic brain injury (TBI) complicated by PSH managed by a physiatry consult team., Results: Three patients, ranging in age from 8 months to 27 years, were admitted with severe TBI complicated by PSH refractory to pharmacologic management. All three patients, however, had resolution of PSH within 24-72 hours of focal spasticity treatments (i.e. casting and botulinum toxin injections)., Conclusion: PSH is a constellation of physiologic findings and physical symptoms that is incompletely understood. Management is based on addressing predominant symptom features and physiologic responses. In certain cases, ongoing spasticity and/or dystonia may serve as noxious stimuli for persistence of PSH in moderate to severe brain injury. As such, the focal treatment of spasticity and/or dystonia may be considered as a treatment target in the management of refractory PSH.
- Published
- 2022
- Full Text
- View/download PDF
14. Effect of prophylactic endoscopic clip placement on clinically significant post-endoscopic mucosal resection bleeding in the right colon: a single-centre, randomised controlled trial.
- Author
-
Gupta S, Sidhu M, Shahidi N, Vosko S, McKay O, Bahin FF, Zahid S, Whitfield A, Byth K, Brown G, Lee EYT, Williams SJ, Burgess NG, and Bourke MJ
- Subjects
- Aged, Colonoscopy, Female, Humans, Male, Middle Aged, Surgical Instruments, Treatment Outcome, Colonic Polyps surgery, Endoscopic Mucosal Resection adverse effects, Postoperative Hemorrhage prevention & control
- Abstract
Background: Endoscopic mucosal resection (EMR) is a cornerstone in the management of large (≥20 mm) non-pedunculated colorectal polyps. Clinically significant post-EMR bleeding occurs in 7% of cases and is most frequently encountered in the right colon. We aimed to assess the use of prophylactic clip closure in preventing clinically significant post-EMR bleeding within the right colon., Methods: We conducted a randomised controlled trial at a tertiary centre in Australia. Patients referred for the EMR of large non-pedunculated colorectal polyps in the right colon were eligible. Patients were randomly assigned (1:1) into the clip or control (no clip) group, using a computerised random-number generator. The primary endpoint was clinically significant post-EMR bleeding, defined as haematochezia necessitating emergency department presentation, hospitalisation, or re-intervention within 14 days post-EMR, which was analysed on the basis of intention-to-treat principles. The trial is registered with ClinicalTrials.gov, NCT02196649, and has been completed., Findings: Between Feb 4, 2016, and Dec 15, 2020, 231 patients were randomly assigned: 118 to the clip group and 113 to the control group. In the intention-to-treat analysis, clinically significant post-EMR bleeding was less frequent in the clip group than in the control group (four [3·4%] of 118 patients vs 12 [10·6%] of 113; p=0·031; absolute risk reduction 7·2% [95% CI 0·7-13·8]; number needed to treat 13·9). There were no differences between groups in adverse events, including delayed perforation (one [<1%] in the clip group vs one [<1%] in the control group) and post-EMR pain (four [3%] vs six [5%]). No deaths were reported., Interpretation: Prophylactic clip closure can be performed following the EMR of large non-pedunculated colorectal polyps of 20 mm or larger in the right colon to reduce the risk of clinically significant post-EMR bleeding., Funding: None., Competing Interests: Declaration of interests MJB receives research support from Olympus, Cook Medical, and Boston Scientific. All other authors declare no competing interests., (Copyright © 2022 Elsevier Ltd. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
15. Simple optical evaluation criteria reliably identify the post-endoscopic mucosal resection scar for benign large non-pedunculated colorectal polyps without tattoo placement.
- Author
-
Shahidi N, Gupta S, Whitfield A, Vosko S, McKay O, Cronin O, Zahid S, Burgess NG, and Bourke MJ
- Subjects
- Cicatrix diagnosis, Cicatrix etiology, Cicatrix pathology, Colonoscopy, Humans, Colonic Polyps diagnostic imaging, Colonic Polyps pathology, Colonic Polyps surgery, Colorectal Neoplasms pathology, Colorectal Neoplasms surgery, Endoscopic Mucosal Resection, Tattooing
- Abstract
Background: Recognition of the post-endoscopic mucosal resection (EMR) scar is critical for large (≥ 20 mm) non-pedunculated colorectal polyp (LNPCP) management. The utility of intraluminal tattooing to facilitate scar identification is unknown., Methods: We evaluated the ability of simple easy-to-use optical evaluation criteria to detect the post-EMR scar, with or without tattoo placement, in a prospective observational cohort of LNPCPs referred for endoscopic resection. The primary outcome was scar identification, further stratified by lesion size (20-39 mm, ≥ 40 mm) and histopathology (adenomatous, serrated)., Results: 1023 LNPCPs underwent both successful EMR and first surveillance colonoscopy (median size 35 mm, IQR 30-50 mm); 124 (12.1 %) had an existing tattoo or a tattoo placed at the index EMR. The post-EMR scar was identified in 1020 patients (99.7 %). The presence of a tattoo did not affect scar identification (100.0 % vs. 99.7 %; P > 0.99). There was no difference for LNPCPs 20-39 mm, LNPCPs ≥ 40 mm, adenomatous LNPCPs, and serrated LNPCPs (all P > 0.99)., Conclusions: The post-EMR scar can be reliably identified with simple easy-to-use optical evaluation criteria, without the need for universal tattoo placement., Competing Interests: Michael J. Bourke has received research support from Olympus, Cook Medical, and Boston Scientific. The remaining authors declare that they have no conflict of interest., (Thieme. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
16. Exceptional Response to Olaparib and Pembrolizumab for Pancreatic Adenocarcinoma With Germline BRCA1 Mutation and High Tumor Mutation Burden: Case Report and Literature Review.
- Author
-
Lundy J, McKay O, Croagh D, and Ganju V
- Subjects
- Adenocarcinoma genetics, Aged, BRCA1 Protein genetics, Germ Cells, Humans, Male, Mutation, Pancreatic Neoplasms genetics, Treatment Outcome, Tumor Burden, Adenocarcinoma drug therapy, Antibodies, Monoclonal, Humanized therapeutic use, Antineoplastic Agents therapeutic use, Pancreatic Neoplasms drug therapy, Phthalazines therapeutic use, Piperazines therapeutic use
- Abstract
Competing Interests: Joanne LundyPatents, Royalties, Other Intellectual Property: Patent pending for molecular diagnostic signature of pancreatic cancer (Inst) Daniel CroaghStock and Other Ownership Interests: Margin-ClearHonoraria: Boston ScientificSpeakers' Bureau: OncoSil (Inst)Patents, Royalties, Other Intellectual Property: Patent on molecular diagnostic signature for pancreatic cancer (Inst), Patent for the brachytherapy device for use at the operative site following resectionOther Relationship: Boston Scientific (Inst) Vinod GanjuHonoraria: Roche/Genentech, AstraZenecaNo other potential conflicts of interest were reported.
- Published
- 2022
- Full Text
- View/download PDF
17. Impact of technical innovations in EMR in the treatment of large nonpedunculated polyps involving the ileocecal valve (with video).
- Author
-
Vosko S, Gupta S, Shahidi N, van Hattem WA, Zahid S, McKay O, Whitfield A, Sidhu M, Tate DJ, Lee EYT, Byth K, Williams SJ, Burgess N, and Bourke MJ
- Subjects
- Colonoscopy, Humans, Retrospective Studies, Treatment Outcome, Colonic Polyps surgery, Endoscopic Mucosal Resection, Ileocecal Valve surgery
- Abstract
Background and Aims: The endoscopic management of large nonpedunculated colorectal polyps involving the ileocecal valve (ICV-LNPCPs) remains challenging because of its unique anatomic features, with long-term outcomes inferior to LNPCPs not involving the ICV. We sought to evaluate the impact of technical innovations and advances in the EMR of ICV-LNPCPs., Methods: The performance of EMR for ICV-LNPCPs was retrospectively evaluated in a prospective observational cohort of LNPCPs ≥20 mm. Efficacy was measured by clinical success (removal of all polypoid tissue during index EMR and avoidance of surgery) and recurrence at first surveillance colonoscopy. Accounting for the adoption of technical innovations, comparisons were made between an historical cohort (September 2008 to April 2016) and contemporary cohort (May 2016 to October 2020). Safety was evaluated by documenting the frequencies of intraprocedural bleeding, delayed bleeding, deep mural injury, and delayed perforation., Results: Between September 2008 to October 2020, 142 ICV-LNPCPs were referred for EMR. Median ICV-LNPCP size was 35 mm (interquartile range, 25-50 mm). When comparing the contemporary (n = 66) and historical cohorts (n = 76) of ICV-LNPCPs, there were significant differences in clinical success (93.9% vs 77.6%, P = .006) and recurrence (4.6% vs 21.0%, P = .019)., Conclusions: With technical advances, ICV-LNPCPs can be effectively and safely managed by EMR, independent of lesion complexity. Most patients experience excellent outcomes and avoid surgery., (Copyright © 2021 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
18. Is it time to consider prophylactic appendectomy in patients with serrated polyposis syndrome undergoing surveillance?
- Author
-
McKay O, Shahidi N, Gupta S, van Hattem WA, El-Khoury T, and Bourke MJ
- Subjects
- Adenomatous Polyposis Coli diagnosis, Adenomatous Polyposis Coli pathology, Colon pathology, Colonoscopy, Humans, Watchful Waiting, Adenomatous Polyposis Coli surgery, Appendectomy
- Abstract
Competing Interests: Competing interests: None declared.
- Published
- 2021
- Full Text
- View/download PDF
19. Human papillomavirus infection in esophageal squamous cell carcinoma and esophageal adenocarcinoma: a concise review.
- Author
-
Rajendra S, Pavey D, McKay O, Merrett N, and Gautam SD
- Subjects
- Adenocarcinoma virology, Adolescent, Adult, Aged, Alphapapillomavirus isolation & purification, Barrett Esophagus pathology, Esophageal Neoplasms virology, Esophageal Squamous Cell Carcinoma virology, Female, Humans, Male, Middle Aged, Papillomavirus Infections epidemiology, Young Adult, Adenocarcinoma pathology, Barrett Esophagus virology, Esophageal Neoplasms pathology, Esophageal Squamous Cell Carcinoma pathology, Papillomavirus Infections pathology
- Abstract
The causal link between high-risk human papillomavirus (hr-HPV) infection and cervical, anogenital, and some oropharyngeal malignancies has been established by both molecular and epidemiological data. The association between HPV and esophageal squamous cell carcinoma (ESCC) remains controversial, as is the true prevalence of HPV infection in ESCC. The wide range in reported rates reflects variability in the primary literature, with some larger scale case-control studies suggesting the infection rates range from 0% to 78%. Interactions between HPV and the Barrett's metaplasia-dysplasia-carcinoma sequence have been explored, and these studies have shown some conflicting data. Overall, systematic reviews have reported the prevalence of HPV-positive DNA in esophageal adenocarcinoma patients of between 13% and 35%. Postulated reasons for discrepancies in HPV prevalence rates in esophageal cancer include variations in testing methodology and assay sensitivities; technical issues, including the lack of a gold-standard primer; types of specimens utilized (fresh-frozen versus formalin-fixed tissue); geographical variation; cross-contamination; and small sample sizes. Thus, efforts must be undertaken to (1) standardize HPV testing, ideally in a central laboratory and utilizing tests that detect viral transcriptional activity; (2) avoid cross-contamination; and (3) recruit large numbers of patients to accurately ascertain HPV rates in esophageal malignancy., (© 2020 New York Academy of Sciences.)
- Published
- 2020
- Full Text
- View/download PDF
20. Management of nonpainful supernumerary phantom limbs after incomplete spinal cord injury with visual-tactile feedback therapy: a case report.
- Author
-
Diaz-Segarra N, McKay O, Kirshblum S, and Yonclas P
- Subjects
- Adult, Humans, Male, Pain drug therapy, Phantom Limb etiology, Spinal Cord Injuries complications, Treatment Outcome, Feedback, Pain Management, Phantom Limb therapy, Spinal Cord Injuries therapy
- Abstract
Introduction: Supernumerary phantom limb (SPL) is an uncommon phantom sensation where the patient experiences the illusory presence of one or more limbs in addition to their existing limbs. SPL after a spinal cord injury (SCI) is rare with few documented cases. There is minimal treatment guidance available, with some reports of visual-tactile feedback therapy used to manage SPL., Case Presentation: A 43-year-old male sustained a C4 ASIA Impairment Scale grade C SCI, developing the sensation of two SPL arms originating from his shoulders 6 days after injury. He developed a self-directed method of visual-tactile feedback as a means to improve the SPL sensations, consisting of shrugging his shoulders repeatedly for 1 min while observing the movement of his actual arms. After completion of this routine, the SPL moved to the same location as his arms, providing relief. Also, an elastic band was placed on a sensate region of his arm, providing additional visual-tactile feedback. The SPL improved and resolved by day 45., Discussion: SPL after SCI is poorly characterized, usually occurring within 6-7 days of injury after a complete or incomplete cervical SCI. While the mechanism is unclear, the inability to integrate visual, tactile, and proprioceptive information after deafferentation may contribute to development. Similarities between SPL and phantom limb sensation after an amputation have resulted in the use of visual and visual-tactile feedback therapy for painful SPL management. This is the first case documenting successful use of visual-tactile feedback therapy to manage nonpainful SPL.
- Published
- 2020
- Full Text
- View/download PDF
21. Association of Biomarkers for Human Papillomavirus With Survival Among Adults With Barrett High-grade Dysplasia and Esophageal Adenocarcinoma.
- Author
-
Rajendra S, Sharma P, Gautam SD, Saxena M, Kapur A, Sharma P, Merrett N, Yang T, Santos LD, Pavey D, Sharaiha O, McKay O, Dixson H, and Xuan W
- Subjects
- Aged, Biomarkers, Tumor genetics, Case-Control Studies, Disease-Free Survival, Female, Humans, Ki-67 Antigen genetics, Male, Middle Aged, Minichromosome Maintenance Complex Component 2 genetics, Papillomaviridae genetics, Prognosis, Retrospective Studies, Adenocarcinoma complications, Adenocarcinoma diagnosis, Adenocarcinoma genetics, Adenocarcinoma mortality, Barrett Esophagus complications, Barrett Esophagus diagnosis, Barrett Esophagus genetics, Barrett Esophagus mortality, Esophageal Neoplasms complications, Esophageal Neoplasms diagnosis, Esophageal Neoplasms genetics, Esophageal Neoplasms mortality, Papillomavirus Infections complications, Papillomavirus Infections genetics
- Abstract
Importance: The presence of high-risk human papillomavirus (HPV) has been associated with a favorable outcome in Barrett high-grade dysplasia (HGD) and esophageal adenocarcinoma (EAC). Nevertheless, the prognostic significance of other HPV-related biomarkers (ie, retinoblastoma protein [pRb], cyclin D1 [CD1], minichromosome maintenance protein [MCM2] and Ki-67) is unknown., Objective: To examine the association between HPV-related biomarkers and survival in adult patients with Barrett HGD and EAC., Design, Setting, and Participants: This retrospective case-control study examined the hypothesis that the HPV-related cell cycle markers (pRb, CD1, and Ki-67) and the viral surrogate marker (MCM2) may be associated with a favorable prognosis in Barrett HGD and EAC. Pretreatment biopsies were used for HPV DNA determination via polymerase chain reaction and immunohistochemistry for the HPV-related biomarkers. Recruitment of patients occurred in secondary and tertiary referral centers, with 151 patients assessed for eligibility. The study period was from December 1, 2002, to November 28, 2017, and the dates of analysis were from September 9, 2011, to November 28, 2017., Main Outcomes and Measures: Disease-free survival and overall survival., Results: Of 151 patients assessed for eligibility, 9 were excluded. Among the 142 patients with Barrett HGD or EAC (126 [88.7%] men; mean [SD] age, 66.0 [12.1] years; 142 [100%] white), 37 were HPV positive and 105 were HPV negative. No association with disease-free survival was noted for pRb, CD1, Ki-67, and MCM2. In regard to overall survival, only low expression of CD1 had a favorable prognosis (hazard ratio [HR], 0.53; 95% CI, 0.30-0.95; adjusted P = .03). All the biomarkers stratified by HPV status showed significant associations with survival. Patients with HPV-positive, low-expression pRb esophageal tumors were associated with a significantly improved disease-free survival compared with the HPV-negative, high-expression Rb tumors (HR, 0.33; 95% CI, 0.12-0.93; adjusted P = .04). Similarly, HPV-positive, low-expression CD1 was associated with a significantly favorable disease-free survival (HR, 0.26; 95% CI, 0.09-0.76; adjusted P = .01), as was HPV-positive, high-expression MCM2 (HR, 0.27; 95% CI, 0.09-0.78; adjusted P = .02). In regard to overall survival, HPV was significantly associated only with low CD1 (HR, 0.38; 95% CI, 0.15-0.94; adjusted P = .04)., Conclusions and Relevance: This study's findings suggest that low expression of CD1 appears to be an independent prognostic marker in Barrett HGD and EAC. Human papillomavirus positivity in combination with pRb, CD1, MCM2, and Ki-67 was associated with a survival benefit in esophageal tumors. These findings suggest the possibility of personalization of therapy for Barrett HGD and EAC based on viral status.
- Published
- 2020
- Full Text
- View/download PDF
22. Is noninvasive ventilation possible only in New Jersey?
- Author
-
McKay O and Bach JR
- Subjects
- Humans, Muscular Dystrophy, Duchenne physiopathology, Muscular Dystrophy, Duchenne therapy, Respiration, Artificial methods
- Published
- 2011
- Full Text
- View/download PDF
23. High air pollution levels in some takeaway food outlets and barbecue restaurants. Pilot study in Wellington City, New Zealand.
- Author
-
Wilson N, Parry R, Jalali J, Jalali R, McLean L, and McKay O
- Subjects
- Air Pollution, Indoor adverse effects, Environmental Monitoring methods, Fast Foods, Female, Humans, Incidence, Male, Maximum Allowable Concentration, New Zealand, Particulate Matter adverse effects, Pilot Projects, Restaurants, Risk Assessment, Urban Population, Air Pollution, Indoor statistics & numerical data, Cooking methods, Environmental Health, Particulate Matter analysis
- Published
- 2011
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.